0001075796-17-000008.txt : 20170717 0001075796-17-000008.hdr.sgml : 20170717 20170717120204 ACCESSION NUMBER: 0001075796-17-000008 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170717 DATE AS OF CHANGE: 20170717 EFFECTIVENESS DATE: 20170717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLI VUL 2 SERIES ACCOUNT CENTRAL INDEX KEY: 0001075796 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-70963 FILM NUMBER: 17967042 BUSINESS ADDRESS: STREET 1: 8515 EAST ORCHARD RD CITY: GREENWOOD VILLAGE STATE: CO ZIP: 80111 BUSINESS PHONE: 303-737-3000 MAIL ADDRESS: STREET 1: 8515 EAST ORCHARD RD CITY: GREENWOOD VILLAGE STATE: CO ZIP: 80111 0001075796 S000011535 COLI VUL 2 SERIES ACCOUNT C000031797 COLI VUL 2 SERIES ACCOUNT 497 1 coli-2gwla2017x06x19497e.htm 497 Document




Rule 497(e)
File Nos. 333-70963 and 811-09201

Executive Benefit VUL - Prospectus
Executive Benefit VUL II - Prospectus

An individual flexible premium variable universal life insurance policy
Issued by
Great-West Life & Annuity Insurance Company

Supplement dated July 17, 2017
to the Prospectus dated May 1, 2017

This Supplement amends certain information contained in the Prospectus dated May 1, 2017.

Great-West Profile Funds Merger:
The merger of the Great-West Profile I Funds (the “Acquired Funds”) into the Great-West Profile II Funds (the “Acquiring Funds”) was completed on or about July 14, 2017 (the “Merger Date”). Effective as of the start of business on the Merger Date, any assets remaining in the Sub-Accounts for the Acquired Funds became invested in the Sub-Accounts for the Acquiring Funds. Contract Owners whose assets became invested in the Sub-Accounts for the Acquiring Funds as a result of the merger may transfer those assets into any other investment option under the Contract without fees or charges, and the transfer will not count against the annual free transfer limit, within 60 days after the Merger Date.

If you have any questions regarding this Supplement, please call us toll free (888) 353-2654.

This Supplement must be accompanied by, and read in conjunction with, the current Prospectus and
Statement of Additional Information dated May 1, 2017.

Please read this Supplement carefully and retain it for future reference.